retatrutide mechanism benefits Retatrutide—A Game Changer in Obesity Pharmacotherapy Retatrutide UK | The Ultimate

Semaglutide GLP-1 is a desirable option for our patients with Type 2 diabetes since it more successfully improves glycemic control

The primary disadvantage is losing Retatrutides glucagon agonism and superior efficacy

AST, aspartate transaminase

Similar to research on LDL-C levels and how the use of GLP-1 RAs such as liraglutide and exenatide can affect it, reports found that liraglutide and exenatide treatment also has insignificant effects on HDL-C [66-68]

The GLP1 journey: from discovery science to therapeutic successes. JCI

While the core patent in India expires in March 2026, the US patent was granted a Patent Term Extension (PTE) that pushes exclusivity to December 2031